NEW YORK - Shares of pharmaceutical companies opened lower Tuesday, with several stocks hitting multiyear lows, as the broader market fell over a surge in oil prices and continued concerns over inflation.
In industry news, Pfizer Inc. said it completed its $195 million acquisition of Encysive Pharmaceuticals.
Here's how some key drug makers performed Tuesday:
Schering-Plough Corp. down 22 cents to $19.44.
Merck & Co. down 58 cents to $36.41, after dropping to a two-year low of $36.12.
Bristol-Myers Squibb Co., down 45 cents, or 2.2 percent, to $20.19, after bottoming out at $20.03, its lowest point in more than 12 years.
Pfizer Inc. down 13 cents to $17.89, after trading as low as $17.71, its lowest point in nearly 11 years.
Six companies in the financial-services sector are being added to the Russell 1000 in this year's reconstitution of the large stock index, wh...
As more Americans rely on charity amid worsening economic gloom, operators of fo...
Thirty-two men and women from across the United States have been selected as Rhodes Scholars for 2009, the scholarship trust announced Sunday. Th...


Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Get your next web design project done with our los angeles web design team - Best web design with great price.